Cygnus Webinars

1. Characterization Of Residual Impurities In Gene Therapy Drug Products 4/12/2023

   This expert discussion focuses on residual impurities for gene therapy drug products, risk assessment, and characterization of product-related impurities in LVV based gene therapy products.

2. Best Practices In HCP Assay Qualification And Bridging To A New Assay 4/12/2023

   Explore a case study using a specific HCP immunoassay and advanced orthogonal Antibody Affinity Extraction and Mass Spectrometry methods for assay qualification.

3. Best Practices In HCP Assay Development And Integration Of Advanced Orthogonal Methods 4/12/2023

   Learn the best practices in HCP immunoassay development, common mistakes and misconceptions , and advanced orthogonal methods of immunoaffinity chromatography and mass spectrometry.

4. Identification Of Downstream Host Cell Protein Impurities 3/23/2021

   This discussion on orthogonal methods, such as immunoaffinity chromatography and mass spectrometry, provides a deeper understanding of HCPs that impact patient safety and drug stability.

5. Predicting LRV Through The Use Of A Non-Infectious MVM Surrogate 3/23/2021

   Discussed here are results from studies that utilized a non-infectious Mock Virus Particle as an MVM surrogate, demonstrating the value to be gained from a QbD approach during process optimization.